James M. Stark

James M. Stark

Auto-generated profile, based on publicly available information

James M. Stark

Department of Pediatrics, Division of Pulmonary Medicine, Allergy-Immunology, and Sleep, McGovern Medical School at UTHealth, 6431 Fannin Street MSB 3.228, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
JKJeremy Katzen
Jeremy Katzen
BWBrandie D. Wagner
Brandie D. Wagner
AVAlessandro Venosa
Alessandro Venosa
MKMeghan Kopp
Meghan Kopp
YTYaniv Tomer
Yaniv Tomer
MBMichael F. Beers
Michael F. Beers
Alveolar type 2 (AT2) cell endoplasmic reticulum (ER) stress is a prominent feature in adult and pediatric interstitial lung disease (ILD and ChILD), but in vivo models linking AT2 cell ER stress to ILD have been elusive. Based on a clinical ChILD case, we identified a critical cysteine residue in the surfactant protein C gene ( SFTPC ) BRICHOS domain whose mutation induced ER stress in vitro. To model this in vivo, we generated a knockin mouse model expressing a cysteine-to-glycine substitution at codon 121 (C121G) in the Sftpc gene. Sftpc C121G expression during fetal development resulted in a toxic gain-of-function causing fatal postnatal respiratory failure from disrupted lung morphogenesis. Induced Sftpc C121G expression in adult mice resulted in an ER-retained pro-protein causing AT2 cell ER stress. Sftpc C121G AT2 cells were a source of cytokines expressed in concert with development of polycellular alveolitis. These cytokines were subsequently found in a high-dimensional proteomic screen of bronchoalveolar lavage fluid from ChILD patients with the same class of SFTPC mutations. Following alveolitis resolution, Sftpc C121G mice developed spontaneous pulmonary fibrosis and restrictive lung impairment. This model provides proof of concept linking AT2 cell ER stress to fibrotic lung disease coupled with translationally relevant biomarkers.

6 February 2018 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
RMRicardo Mosquera
Ricardo Mosquera
WJWilfredo De Jesus‐Rojas
Wilfredo De Jesus‐Rojas
JSJames M. Stark
James M. Stark
AYAravind Yadav
Aravind Yadav
CJCindy K. Jon
Cindy K. Jon
GCGiuseppe N. Colasurdo
Giuseppe N. Colasurdo

10 September 1996 in Human Gene Therapy
Verified
Journal Article
Closed access
JSJames M. Stark
James M. Stark
RARaouf S. Amin
Raouf S. Amin
BTBruce C. Trapnell
Bruce C. Trapnell
A significant number of pulmonary exacerbations in patients with cystic fibrosis (CF) and asthma are associated with respiratory virus infections. The molecular mediators of this process are beginning to be understood. Viral infection of respiratory epithelial cultures in vitro leads to the production of intercellular adhesion molecule-1 (ICAM-1) (a ligand for inflammatory cell adhesion and activation) and a number of proinflammatory cytokines. Human gene therapy vectors derived from human adenoviruses (AV) are currently under evaluation for CF transmembrane regulator (CFTR) gene delivery to the airway epithelium of CF patients. However, studies in animal models using these AV vectors demonstrate pulmonary inflammation following AV exposure. Using an in vitro model, we examined the hypothesis that exposure of respiratory epithelial cells to AV vectors results in upregulation of ICAM-1 gene expression. Infections were performed using a replication-deficient, first-generation AV vector. A549 cells (a human pulmonary adenocarcinoma cell line) were exposed to AV at multiplicity of infection of 50–150 plaque-forming units/cell (resulting in >90% of cells expressing the reporter gene by 48 hr following exposure). Measurements of ICAM-1 expression were made at time intervals following virus exposure using enzyme immunoassay, flow cytometry, and Northern blot analysis. Cell-bound ICAM-1 was significantly increased 96 hr following vector exposure, two to four times control, p < 0.001). The AV-exposed A549 cells also supported increased levels of adhesion of activated neutrophils 96 hr following AV exposure (four times control, p < 0.001) that was blocked by antibody to CD18. AV exposure of A549 monolayers increases expression of biologically active ICAM-1. Strategies to minimize host cellular proinflammatory responses to the replication-deficient AV vectors may improve their safety for gene therapy. Adenovirus (AV) vectors have been proposed for the transfer of the normal human cystic fibrosis transmembrane regulator (CFTR) cDNA to the airway epithelium of patient with cystic fibrosis (CF). In the present study, we report that the first-generation AV vector, Av1LacZ4, up-regulates intercellular adhesion molecule-1 (ICAM-1) gene expression by A549 (immortalized respiratory epithelial-like cells) in vitro.

1 September 2015 in Pediatric Allergy, Immunology, and Pulmonology
Verified
Journal Article
Open access
AYAravind Yadav
Aravind Yadav
FMFernando F Corrales-Medina, MD
Fernando F Corrales-Medina, MD
JSJames M. Stark
James M. Stark
SHSyed Shahrukh Hashmi
Syed Shahrukh Hashmi
MCMary P. Carroll
Mary P. Carroll
RMRicardo Mosquera
Ricardo Mosquera
Objective: Asthma in sickle cell disease (SCD) patients is associated with elevated morbidity and mortality. Early detection and initiation of treatment may therefore lead to improved outcome. Utility of an asthma screening questionnaire to identify obstructive airway disease and physician diagnosed asthma in children with SCD at an outpatient setting as an effective, easy-to-administer screening tool has not previously been evaluated in this population. Methods: A previously validated asthma screening questionnaire and spirometry were prospectively administered to 41 SCD children at a routine clinic visit. Results: Prevalence of obstructive airway was 51.2% ( n = 21) and physician diagnosis of asthma 33.3% ( n = 13). Sensitivity (40%) and specificity (75%) of the questionnaire was poor in detecting obstructive airway disease, but sensitivity (77%), specificity (100%), positive predictive value (100%), and negative predictive value (90%) were high in detecting physician diagnosis of asthma. Conclusion: An asthma screening questionnaire could be a useful tool in identifying at-risk SCD children who may benefit from further management.

21 November 2020 in Pediatric Clinics of North America
Verified
Journal Article
Closed access
SPSusan E. Pacheco
Susan E. Pacheco
JSJames M. Stark
James M. Stark

1 October 2014 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
CJCindy Jon
Cindy Jon
SMSarah E. Mitchell
Sarah E. Mitchell
RMRicardo Mosquera
Ricardo Mosquera
JSJames M. Stark
James M. Stark
SYSancak Yuksel
Sancak Yuksel